#Tumors

From Dev.to - beginners: Proton Therapy in China: A Complete Guide for International Patients (2026)

ANL shifts to early RAS-targeting and immuno-oncology after Phase 3 failure; PIPE/ASK funding boosts cash. Click here to read my most recent analysis.

A key protein, HOXD13, helps melanoma tumors grow and evade the immune system by boosting blood supply and blocking cancer-fighting T cells. Disabling it shrinks tumors and reopens the door for the immune system—offering a new path for treatment.

Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease progression remains a major hurdle.…